Author:
Chaudhry Burhan Z.,Cohen Jeffrey A.,Conway Devon S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference46 articles.
1. Radick L, Mehr SR. The latest innovations in the drug pipeline for multiple sclerosis. Am Health Drug Benefits 2015;8;448-53
2. Gonzalez-Cabrera PJ, Brown S, Studer SM, Rosen H. S1P signaling: new therapies and opportunities. F1000prime Rep 2014;6:109.
3. Urbano M, Guerrero M, Rosen H, Roberts E. Modulators of the sphingosine 1-phosphate receptor 1. Bioorg Med Chem Lett 2013;23:6377-89.
4. Aktas O, Kury P, Kieseier B, Hartung HP. Fingolimod is a potential novel therapy for multiple sclerosis. Nat Rev Neurol 2010;6:373-82.
5. Chun J, Hartung HP. Mechanism of action of oral fingolimod [FTY720] in multiple sclerosis. Clin Neuropharmacol 2010;33:91-101.
Cited by
111 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献